Nature Communications, Published online: 05 September 2026; doi:10.1038/s41467-026-77312-7 This study reveals how subtle changes in ligand structure control signaling bias at the immunometabolic receptor GPR84, providing structural details for the rational design of drugs with tailored signalling properties.